Deepening Capital in India’s Healthtech Ecosystem
HealthQuad, the Quadria Group-backed venture firm, has successfully reached the first close of its third fund, securing Rs 550 crore ($65M+). The fund, which aims for a total target corpus of Rs 1,700 crore, continues the firm’s focused mandate on transforming India’s healthcare landscape through technology-led disruption.
Investment Mandate and Focus Areas
HealthQuad Fund III is specifically targeting early-growth-stage startups across four core pillars:
- Healthtech
- Medtech
- Biopharma Technology
- Healthcare Delivery
These segments are positioned for significant tailwinds, with projections suggesting they will account for over 40% of India’s anticipated $600 billion healthcare market by 2030.
Track Record and Strategic Shift
Since its inception in 2016, HealthQuad has established itself as a cornerstone investor in the Indian healthcare ecosystem. With over 18 investments under its belt, the firm boasts a portfolio featuring notable names such as Qure.ai, Wysa, Medikabazaar, and Redcliffe Labs. The management team—led by Amit Varma, Abrar Mir, and Sunil Thakur—has recently solidified its internal structure following its 2025 separation from KOIS, bolstering leadership with the addition of Rahul Agarwal and Namit Chugh.
First Deployment
The firm signaled its operational intent immediately, announcing the first deployment from Fund III into Lifesigns, an AI-powered remote patient monitoring platform, indicating a continued focus on high-acuity, tech-enabled clinical outcomes.
Founder Takeaway
For healthtech founders, HealthQuad remains a critical partner that offers more than just capital; their deep sectoral focus and network within the Quadria Group ecosystem provide significant strategic leverage for navigating India’s complex healthcare regulatory and delivery infrastructure.